Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1935 1
1962 1
1982 3
1983 4
1984 3
1985 3
1986 1
1987 7
1988 10
1989 9
1990 6
1991 6
1992 4
1993 10
1994 3
1995 3
1996 2
1997 2
1998 2
1999 4
2000 4
2001 4
2002 2
2003 5
2004 4
2005 6
2006 7
2007 4
2008 2
2009 4
2010 6
2011 5
2012 5
2013 5
2014 3
2015 8
2016 7
2017 5
2018 10
2019 7
2020 6
2021 5
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

200 results

Results by year

Filters applied: . Clear all
Page 1
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, Richeldi L, Kolb M, Tetzlaff K, Stowasser S, Coeck C, Clerisme-Beaty E, Rosenstock B, Quaresma M, Haeufel T, Goeldner RG, Schlenker-Herceg R, Brown KK; INBUILD Trial Investigators. Flaherty KR, et al. N Engl J Med. 2019 Oct 31;381(18):1718-1727. doi: 10.1056/NEJMoa1908681. Epub 2019 Sep 29. N Engl J Med. 2019. PMID: 31566307 Clinical Trial.
Bronchiectasis and inhaled tobramycin: A literature review.
Elborn JS, Blasi F, Haworth CS, Ballmann M, Tiddens HAWM, Murris-Espin M, Chalmers JD, Cantin AM. Elborn JS, et al. Among authors: cantin am. Respir Med. 2022 Feb;192:106728. doi: 10.1016/j.rmed.2021.106728. Epub 2022 Jan 1. Respir Med. 2022. PMID: 34998112 Free article. Review.
Cystic Fibrosis: Pathophysiology of Lung Disease.
Bergeron C, Cantin AM. Bergeron C, et al. Among authors: cantin am. Semin Respir Crit Care Med. 2019 Dec;40(6):715-726. doi: 10.1055/s-0039-1694021. Epub 2019 Oct 28. Semin Respir Crit Care Med. 2019. PMID: 31659725 Review.
Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, Moua T, Crestani B, Wuyts WA, Stowasser S, Quaresma M, Goeldner RG, Schlenker-Herceg R, Kolb M; INBUILD trial investigators. Wells AU, et al. Lancet Respir Med. 2020 May;8(5):453-460. doi: 10.1016/S2213-2600(20)30036-9. Epub 2020 Mar 5. Lancet Respir Med. 2020. PMID: 32145830 Clinical Trial.
Synthesis and Characterization of a Phosphate Prodrug of Isoliquiritigenin.
Boyapelly K, Bonin MA, Traboulsi H, Cloutier A, Phaneuf SC, Fortin D, Cantin AM, Richter MV, Marsault E. Boyapelly K, et al. Among authors: cantin am. J Nat Prod. 2017 Apr 28;80(4):879-886. doi: 10.1021/acs.jnatprod.6b00600. Epub 2017 Mar 2. J Nat Prod. 2017. PMID: 28252963
Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study.
Mahmoud SH, Hefny FR, Panos NG, Delucilla L, Ngan Z, Perreault MM, Hamilton LA, Rowe AS, Buschur PL, Owusu-Guha J, Almohaish S, Sandler M, Armahizer MJ, Barra ME, Cook AM, Barthol CA, Hintze TD, Cantin A, Traeger J, Blunck JR, Shewmaker J, Burgess SV, Kaupp K, Brown CS, Clark SL, Wieruszewski ED, Tesoro EP, Ammar AA, Ammar MA, Binning MJ, Naydin S, Fox N, Peters DM Jr, Mahmoud LN, Keegan SP, Brophy GM. Mahmoud SH, et al. Among authors: cantin a. Pharmacotherapy. 2023 Apr;43(4):279-290. doi: 10.1002/phar.2791. Epub 2023 Mar 16. Pharmacotherapy. 2023. PMID: 36880540
200 results